Iantrek

We’re excited to announce the release of Spannula™, Iantrek’s latest innovation designed to help surgeons efficiently create a cyclodialysis cleft during glaucoma surgery.    Developed with surgical precision and workflow in mind, Spannula expands the toolkit available to surgeons exploring approaches that leverage the uveoscleral pathway. We look forward to sharing more with the ophthalmic community as surgeons begin incorporating this new instrument into their surgical practice.    #Glaucoma #Ophthalmology #SurgicalInnovation #Iantrek  

The theme for Healthy Vision Month 2026 is “Healthy Lives, Healthy Eyes.” 👁️ At Iantrek, we honor this mission by developing technologies that work in harmony with the body’s natural physiology. Our goal is simple: to help surgeons preserve the gift of sight through bio-interventional excellence. Whether it’s through early detection or advanced micro-interventional surgery, let’s make eye health a priority this May. #HealthyVisionMonth #EyeHealth #Innovation #Iantrek #OphthalmicSurgery

Today, we celebrate the mothers, grandmothers, caregivers, and role models who help make the world brighter every day. 💐 At Iantrek, we’re especially grateful for the women who inspire us through their strength, compassion, leadership, and dedication — both at home and throughout the healthcare community. This Mother’s Day, we honor all the incredible moms making a difference in the lives of their families, patients, colleagues, and communities. Wishing you a joyful and well-deserved Mother’s Day! 💖 #MothersDay #Healthcare #Ophthalmology #Glaucoma #Iantrek #MedTech

This past weekend, Iantrek was honored to host three surgeon-led dinners with Dr. Arsham Sheybani, Dr. Philip Ngai, MD, MBA, MS, and Dr. Gagan Sawhney focused on one of the field’s most pressing unmet needs: the post-MIGS patient experiencing waning efficacy. With approximately 3 million eyes in the U.S. estimated to be candidates for alloflo™ uveo, surgeons are increasingly seeking new ways to address post-MIGS patients who remain in need of additional outflow enhancement. As a result, interest continues to grow around surgically unlocking uveoscleral outflow enhancement as the next step in interventional glaucoma care. Alloflo™ is helping address this critical gap — and the momentum behind bio-interventional care continues to grow. Learn more about the clinical impact of alloflo™: https://lnkd.in/en3rheic #Ophthalmology #Glaucoma #Innovation #alloflo #Iantrek #MedTech

A recent MIGS survey conducted by Wall Street investment and analyst firm, Stifel Financial Corp. found that AlloFlo Uveo is one of the most exciting innovations in glaucoma today amongst ophthalmologists. The survey reflects what we’re hearing across the market: surgeons are carrying the interventional glaucoma mindset forward—seeking new options for patients with prior MIGS who are now experiencing waning efficacy, representing approximately 3 million eyes in the U.S. To those unlocking uveoscleral outflow—thank you for helping define what’s next. And to those getting started, we’re excited to support you. #Glaucoma #Innovation #UveoscleralOutflowUnlocked

Check out our CEO, Adam Szaronos, in his recent interview with Eyewire+ at ASCRS. Adam discusses the second addition to our Allo pipeline: AlloSpan™ Uveo. This first-of-its-kind platform empowers surgeons to deliver a complete canaloplasty using natural, biocompatible tissue—offering a lasting solution that mirrors the eye’s natural physiology. We are extremely excited about this announcement and the future of bio-interventional surgery. #ASCRS2026 #Ophthalmology #Iantrek #AlloSpanUveo #Glaucoma #MedTech #Innovation

Last chance! Time is running out to own this one-of-a-kind mural: https://lnkd.in/edM6SSrc Created during ASCRS, the Iantrek Canvas of Innovation is a collective moment captured in paint—each brushstroke added by the surgeons shaping the future of ophthalmology. Most importantly, all proceeds from this auction will be donated to the Glaucoma Research Foundation to support their mission of finding a cure. Don’t miss your opportunity to own a piece of our community's history while supporting a vital cause. Place your final bids now! #ASCRS #Ophthalmology #Glaucoma #Innovation #Iantrek #paintyourpath #UveoscleralOutflowUnlocked #ThePathAwaits #AlloFloUveo #GlaucomaInnovation

Don’t miss your chance to own a truly unique piece created by the surgeons shaping the future of ophthalmology: https://lnkd.in/edM6SSrc This mural is more than artwork--it’s a collective moment captured in paint. During ASCRS, surgeons stepped up to the Iantrek Canvas of Innovation, each adding their own brushstroke to create a piece that reflects collaboration, innovation, and the spirit of the ophthalmic community.   There’s still time to place your bids on this one-of-a-kind mural.   #ASCRS #Ophthalmology #Glaucoma #Innovation #Iantrek #paintyourpath #UveoscleralOutflowUnlocked #ThePathAwaits #AlloFloUveo #GlaucomaInnovation

We’re incredibly proud of this moment for our Founder, Sean Ianchulev MD MPH, who delivered the Kelman Innovator Keynote lecture on the main stage at the ASCRS Annual Meeting.   This recognition is a testament to his dedication to innovation and advancing the future of ophthalmology. Dr. Ianchulev shared his perspective on emerging technologies and what lies ahead for the field--and for Iantrek.   Watch the full lecture here: https://lnkd.in/eHHQJ9Pi #ASCRS #Ophthalmology #Glaucoma #Innovation #Iantrek #paintyourpath #UveoscleralOutflowUnlocked #ThePathAwaits #AlloFloUveo #Iantrek #GlaucomaInnovation American Society of Cataract and Refractive Surgery (ASCRS)

Thank you to everyone who connected with us at ASCRS. We’re grateful to the many surgeons, colleagues, and partners who stopped by the Iantrek booth, participated in our hands-on dry labs, joined our booth talks, and attended our dinner programs.     The thoughtful conversations and shared commitment to advancing care made this meeting incredibly meaningful. We appreciate the opportunity to learn from this community and continue building momentum together. Looking forward to continuing the conversation! And don’t forget, there’s still time to place your bid on the Iantrek Canvas of Innovation. The bids are still rolling in, so don’t miss your chance to own this one-of-a-kind piece of art: https://lnkd.in/edM6SSrc #ASCRS #Ophthalmology #Glaucoma #Innovation #Iantrek #paintyourpath #UveoscleralOutflowUnlocked #ThePathAwaits #AlloFloUveo #Iantrek #GlaucomaInnovation American Society of Cataract and Refractive Surgery (ASCRS)